Cocrystal Pharma, Inc. (FRA:8CC)
0.8800
+0.0350 (4.14%)
At close: Dec 1, 2025
Cocrystal Pharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 7.73 | 9.86 | 26.35 | 37.14 | 58.71 | 33.01 | Upgrade |
Cash & Short-Term Investments | 7.73 | 9.86 | 26.35 | 37.14 | 58.71 | 33.01 | Upgrade |
Cash Growth | -40.64% | -62.59% | -29.05% | -36.73% | 77.84% | 345.00% | Upgrade |
Accounts Receivable | - | - | - | - | - | 0.56 | Upgrade |
Other Receivables | 0.51 | 1.22 | 0.89 | 0.72 | - | - | Upgrade |
Receivables | 0.51 | 1.22 | 0.89 | 0.72 | - | 0.56 | Upgrade |
Prepaid Expenses | 0.47 | 0.43 | 1.77 | 0.54 | 0.57 | 0.4 | Upgrade |
Restricted Cash | 0.08 | 0.08 | 0.08 | 0.08 | 0.05 | 0.05 | Upgrade |
Other Current Assets | - | - | - | 1.7 | - | - | Upgrade |
Total Current Assets | 8.78 | 11.58 | 29.09 | 40.18 | 59.32 | 34.02 | Upgrade |
Property, Plant & Equipment | 1.57 | 1.85 | 2.12 | 0.62 | 0.93 | 1.09 | Upgrade |
Goodwill | - | - | - | - | 19.09 | 19.09 | Upgrade |
Other Long-Term Assets | 0.09 | 0.03 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade |
Total Assets | 10.45 | 13.46 | 31.26 | 40.84 | 79.39 | 54.24 | Upgrade |
Accounts Payable | 0.75 | 1.54 | 1.22 | 0.61 | 0.58 | 0.66 | Upgrade |
Accrued Expenses | 0.45 | 0.59 | 1.8 | 0.36 | 0.72 | 0.42 | Upgrade |
Current Portion of Leases | 0.33 | 0.3 | 0.24 | 0.24 | 0.24 | 0.22 | Upgrade |
Other Current Liabilities | - | - | - | - | 0.01 | 0.06 | Upgrade |
Total Current Liabilities | 1.52 | 2.43 | 3.26 | 1.22 | 1.55 | 1.36 | Upgrade |
Long-Term Leases | 1.26 | 1.51 | 1.61 | 0.06 | 0.3 | 0.38 | Upgrade |
Total Liabilities | 2.78 | 3.93 | 4.88 | 1.27 | 1.84 | 1.74 | Upgrade |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.07 | Upgrade |
Additional Paid-In Capital | 347.48 | 342.93 | 342.29 | 337.49 | 336.63 | 297.34 | Upgrade |
Retained Earnings | -339.82 | -333.42 | -315.91 | -297.93 | -259.09 | -244.91 | Upgrade |
Total Common Equity | 7.67 | 9.52 | 26.38 | 39.57 | 77.55 | 52.51 | Upgrade |
Shareholders' Equity | 7.67 | 9.52 | 26.38 | 39.57 | 77.55 | 52.51 | Upgrade |
Total Liabilities & Equity | 10.45 | 13.46 | 31.26 | 40.84 | 79.39 | 54.24 | Upgrade |
Total Debt | 1.58 | 1.81 | 1.85 | 0.3 | 0.53 | 0.6 | Upgrade |
Net Cash (Debt) | 6.15 | 8.05 | 24.5 | 36.85 | 58.17 | 32.41 | Upgrade |
Net Cash Growth | -44.85% | -67.13% | -33.51% | -36.66% | 79.46% | 391.05% | Upgrade |
Net Cash Per Share | 0.59 | 0.79 | 2.54 | 4.52 | 7.90 | 7.04 | Upgrade |
Filing Date Shares Outstanding | 13.78 | 10.17 | 10.17 | 8.14 | 8.12 | 5.96 | Upgrade |
Total Common Shares Outstanding | 13.04 | 10.17 | 10.17 | 8.14 | 8.12 | 5.87 | Upgrade |
Working Capital | 7.26 | 9.15 | 25.83 | 38.96 | 57.78 | 32.66 | Upgrade |
Book Value Per Share | 0.59 | 0.94 | 2.59 | 4.86 | 9.55 | 8.94 | Upgrade |
Tangible Book Value | 7.67 | 9.52 | 26.38 | 39.57 | 58.46 | 33.41 | Upgrade |
Tangible Book Value Per Share | 0.59 | 0.94 | 2.59 | 4.86 | 7.20 | 5.69 | Upgrade |
Machinery | 1.93 | 1.92 | 1.91 | 1.76 | 1.69 | 1.62 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.